
HDL vs ESPR
$HDL vs $ESPR head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
HDL vs ESPR: the quick read
- ·HDL is the larger company by market cap ($824M vs $819M).
- ·ESPR has the smaller float (253.1M vs 650.3M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (UNKNOWN vs PHARMACEUTICAL PREPARATIONS), so they answer to different catalysts and a move in one says little about the other.
- ·They are closely matched in size, within 1% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both sit in the bottom quarter of their 52-week range, so this is a comparison of two names well off their highs.
- ·HDL pays a dividend and ESPR does not, which usually means one is being held for income and the other for the move.
- ·They are pulling apart today: HDL is outperforming the other by roughly 100.0 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing HDL and ESPR on TheDesperateTrader.
- Is HDL or ESPR the better stock?
- "Better" depends on your goal, and these two are not alike. HDL is the larger company by market cap ($824M vs $819M). ESPR has the smaller float (253.1M vs 650.3M), which tends to mean sharper, more volatile moves. These sit in different industries (UNKNOWN vs PHARMACEUTICAL PREPARATIONS), so they answer to different catalysts and a move in one says little about the other. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between HDL and ESPR?
- The differences that matter: they are not in the same business - HDL is unknown and ESPR is pharmaceutical preparations; they are similar in size ($824M vs $819M); HDL sits at 22% of its 52-week range against -76% for ESPR; only HDL pays a dividend. Everything above is measured from the latest completed session and SEC filings.
- Which of HDL and ESPR is more active right now?
- Neither is showing unusual volume on the latest session, so nothing here is being driven by a volume spike. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading HDL or ESPR? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.